Fig. 3: Genomic Landscape.

Genomic Landscape in cohort of tumors with bTMB ≥10 (TMB-H) and bTMB ≤10 (TMB-L) (A) and bTMB-H ( ≥ 10 mut/Mb) only patients stratified by MSI (B), followed by tumors with bTMB ≥16 (bTMB-H) and bTMB ≤16 (bTMB-L) (C) and then bTMB-H ( ≥ 16 mut/Mb) only patients stratified by MSI (D).